• 30th November 2020

  • -

  • 2nd December 2020

Mitochondrial disorders have emerged as a major cause of inherited human disease. Although the past decade has seen major advances in our understanding of their genetic basis and the underlying pathology, these findings have yet to translate into new therapies. This conference will build new partnerships that harness our understanding of the disease mechanisms, accelerating the pace of effective treatments for mitochondrial diseases. This year’s meeting will include pre-clinical models for mitochondrial disease, an update on current clinical trials, a discussion on the importance on informatics and data sharing for precision medicine and regulatory guidance from a range of international agencies. We will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine. opics will include: Mitochondrial medicine – pharma and funding perspectives Pre-clinical mitochondrial disease models Clinical trials Informatics and data sharing to support precision medicine Regulatory guidance for therapeutic development Deadlines: abstracts (6 October) | registration (23 November)